文献速递神经创伤神经重症

脑组织氧分压联合颅内压监测与单独颅内压监测在创伤性脑损伤患者中的比较:随机对照试验的更新Meta分析

Brain tissue oxygen plus intracranial pressure monitoring versus isolated intracranial pressure monitoring in patients with traumatic brain injury: an updated meta-analysis of randomized controlled trials.
PubMed 文献 · Acta Neurochir (Wien) · 2024-05-30

该更新Meta分析纳入4项随机对照试验共505例中重度创伤性脑损伤患者,比较联合脑组织氧分压(PbtO2)与颅内压(ICP)监测和单独ICP监测。结果显示两组6个月良好预后、死亡率、心血管事件及脓毒症均无显著差异,但联合监测组肺部事件风险显著更高(RR 1.44;95%CI 1.11-1.87;p=0.006;I²=0%)。

要点

  • 联合PbtO2+ICP监测与单独ICP监测相比,6个月良好预后(RR 1.17;95%CI 0.95-1.43;p=0.134)和死亡率(RR 0.82;95%CI 0.57-1.18;p=0.281)均无显著差异。
  • 联合监测组肺部事件风险显著高于单独ICP监测组(RR 1.44;95%CI 1.11-1.87;p=0.006;I²=0%)。
  • 心血管事件(RR 1.75;95%CI 0.86-3.52;p=0.120)和脓毒症(RR 0.75;95%CI 0.25-2.22;p=0.604)在两组间无显著差异。

核心结论

  • 联合PbtO2+ICP监测未改变创伤性脑损伤患者的死亡率、功能恢复、心血管事件或脓毒症结局,但联合监测患者肺部事件风险更高。

研究设计与样本

  • 系统检索PubMed、Embase和Cochrane Central数据库,纳入比较联合PbtO2+ICP监测与单独ICP监测在中重度创伤性脑损伤患者中应用的随机对照试验。
  • 共纳入4项随机对照试验,总计505例患者,其中联合PbtO2+ICP监测组241例(47.72%)。

主要发现

  • 6个月良好预后(GOS≥4或GOSE≥5):联合监测组与单独ICP监测组相比无显著差异(RR 1.17;95%CI 0.95-1.43;p=0.134;I²=0%)。
  • 6个月死亡率:联合监测组与单独ICP监测组相比无显著差异(RR 0.82;95%CI 0.57-1.18;p=0.281;I²=34%)。
  • 心血管事件:联合监测组与单独ICP监测组相比无显著差异(RR 1.75;95%CI 0.86-3.52;p=0.120;I²=0%)。
  • 脓毒症:联合监测组与单独ICP监测组相比无显著差异(RR 0.75;95%CI 0.25-2.22;p=0.604;I²=0%)。
  • 肺部事件:联合监测组风险显著高于单独ICP监测组(RR 1.44;95%CI 1.11-1.87;p=0.006;I²=0%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intracranial pressure (ICP) monitoring plays a key role in patients with traumatic brain injury (TBI), however, cerebral hypoxia can occur without intracranial hypertension. Aiming to improve neuroprotection in these patients, a possible alternative is the association of Brain Tissue Oxygen Pressure (PbtO2) monitoring, used to detect PbtO2 tension. METHOD: We systematically searched PubMed, Embase and Cochrane Central for RCTs comparing combined PbtO2 + ICP monitoring with ICP monitoring alone in patients with severe or moderate TBI. The outcomes analyzed were mortality at 6 months, favorable outcome (GOS ≥ 4 or GOSE ≥ 5) at 6 months, pulmonary events, cardiovascular events and sepsis rate. RESULTS: We included 4 RCTs in the analysis, totaling 505 patients. Combined PbtO2 + ICP monitoring was used in 241 (47.72%) patients. There was no significant difference between the groups in relation to favorable outcome at 6 months (RR 1.17; 95% CI 0.95-1.43; p = 0.134; I2 = 0%), mortality at 6 months (RR 0.82; 95% CI 0.57-1.18; p = 0.281; I2 = 34%), cardiovascular events (RR 1.75; 95% CI 0.86-3.52; p = 0.120; I2 = 0%) or sepsis (RR 0.75; 95% CI 0.25-2.22; p = 0.604; I2 = 0%). The risk of pulmonary events was significantly higher in the group with combined PbtO2 + ICP monitoring (RR 1.44; 95% CI 1.11-1.87; p = 0.006; I2 = 0%). CONCLUSIONS: Our findings suggest that combined PbtO2 + ICP monitoring does not change outcomes such as mortality, functional recovery, cardiovascular events or sepsis. Furthermore, we found a higher risk of pulmonary events in patients undergoing combined monitoring.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Pustilnik HN, Medrado-Nunes GS, Cerqueira GA, et al. Brain tissue oxygen plus intracranial pressure monitoring versus isolated intracranial pressure monitoring in patients with traumatic brain injury: an updated meta-analysis of randomized controlled trials. Acta Neurochir (Wien). 2024. PMID: 38814348. doi:10.1007/s00701-024-06125-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。